Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sierra Oncology Inc
(NQ:
SRRA
)
54.99
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 30, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Sierra Oncology Inc
< Previous
1
2
Next >
Sierra Oncology Reports Third Quarter 2021 Results
November 05, 2021
From
Sierra Oncology
Via
Business Wire
Sierra Oncology Announces Momelotinib Poster Accepted for Presentation at ASH
November 04, 2021
From
Sierra Oncology
Via
Business Wire
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
November 03, 2021
From
Sierra Oncology
Via
Business Wire
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 04, 2021
From
Sierra Oncology
Via
Business Wire
Sierra Oncology to Present at Three September Investor Conferences
September 07, 2021
From
Sierra Oncology
Via
Business Wire
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
September 03, 2021
From
Sierra Oncology
Via
Business Wire
Sierra Oncology Provides Update to Momelotinib Development Timeline and Closes on $34 Million in Additional Funding
August 09, 2021
From
Sierra Oncology
Via
Business Wire
Sierra Oncology Reports Second Quarter 2021 Results
August 05, 2021
From
Sierra Oncology
Via
Business Wire
Sierra Oncology Signs Exclusive Global In-Licensing Agreement with AstraZeneca for Novel BET Inhibitor to Expand Myelofibrosis Pipeline
August 05, 2021
From
Sierra Oncology
Via
Business Wire
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
August 05, 2021
From
Sierra Oncology
Via
Business Wire
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
July 22, 2021
From
Sierra Oncology
Via
Business Wire
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
July 07, 2021
From
Sierra Oncology
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.